Literature DB >> 28603053

Colonic Diverticula Are Not Associated With Mucosal Inflammation or Chronic Gastrointestinal Symptoms.

Anne F Peery1, Temitope O Keku2, Cassandra Addamo2, Amber N McCoy2, Christopher F Martin2, Joseph A Galanko2, Robert S Sandler2.   

Abstract

BACKGROUND & AIMS: Colonic diverticulosis has been reported to be associated with low-grade mucosal inflammation, possibly leading to chronic gastrointestinal symptoms. However, there is poor evidence for this association. We aimed to determine mucosal inflammation and whether diverticula are associated with chronic gastrointestinal symptoms. We explored whether inflammation was present among symptomatic participants with and without diverticula.
METHODS: We analyzed data from a prospective study of 619 patients undergoing a screening colonoscopy from 2013 through 2015 at the University of North Carolina Hospital in Chapel Hill, North Carolina. Among our participants, 255 (41%) had colonic diverticula. Colonic mucosal biopsy specimens were analyzed for levels of interleukin 6 (IL6), IL10, and tumor necrosis factor messenger RNAs by quantitative reverse-transcriptase polymerase chain reaction, and numbers of immune cells (CD4+, CD8+, CD57+, and mast cell tryptase) by immunohistochemistry. Gastrointestinal symptoms were assessed using Rome III criteria. Proportional odds models were used to estimate odds ratios (ORs) and 95% confidence interval (CIs).
RESULTS: After adjustment for potential confounders, there was no association between diverticulosis and tumor necrosis factor (OR, 0.85; 95% CI, 0.63-1.16), and no association with CD4+ cells (OR, 1.18; 95% CI, 0.87-1.60), CD8+ cells (OR, 0.97; 95% CI, 0.71-1.32), or CD57+ cells (OR, 0.80; 95% CI, 0.59-1.09). Compared with controls without diverticulosis, biopsy specimens from individuals with diverticulosis were less likely to express the inflammatory cytokine IL6 (OR, 0.59; 95% CI, 0.36-0.96). There was no association between diverticulosis and irritable bowel syndrome (OR, 0.53; 95% CI, 0.26-1.05) or chronic abdominal pain (OR, 0.68; 95% CI, 0.38-1.23). There was no evidence for inflammation in patients with symptoms when patients with vs without diverticulosis were compared.
CONCLUSIONS: We found no evidence that colonic diverticulosis is associated with mucosal inflammation or gastrointestinal symptoms. Among patients with symptoms and diverticula, we found no mucosal inflammation.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Irritable Bowel Syndrome; Painful Diverticular Disease; Symptomatic Diverticulosis; Symptomatic Uncomplicated Diverticular Disease

Mesh:

Substances:

Year:  2017        PMID: 28603053      PMCID: PMC5722710          DOI: 10.1016/j.cgh.2017.05.051

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  24 in total

Review 1.  Diagnosis and treatment of diverticular disease: results of a consensus development conference. The Scientific Committee of the European Association for Endoscopic Surgery.

Authors:  L Köhler; S Sauerland; E Neugebauer
Journal:  Surg Endosc       Date:  1999-04       Impact factor: 4.584

Review 2.  Immunity, inflammation, and allergy in the gut.

Authors:  Thomas T Macdonald; Giovanni Monteleone
Journal:  Science       Date:  2005-03-25       Impact factor: 47.728

Review 3.  Burden of digestive diseases in the United States part II: lower gastrointestinal diseases.

Authors:  James E Everhart; Constance E Ruhl
Journal:  Gastroenterology       Date:  2009-01-21       Impact factor: 22.682

4.  Symptomatic Diverticulosis Is Characterized By Loose Stools.

Authors:  M Ellionore Järbrink-Sehgal; Anna Andreasson; Nicholas J Talley; Lars Agréus; Jeong-Yeop Song; Peter T Schmidt
Journal:  Clin Gastroenterol Hepatol       Date:  2016-06-21       Impact factor: 11.382

5.  The impact of confounder selection criteria on effect estimation.

Authors:  R M Mickey; S Greenland
Journal:  Am J Epidemiol       Date:  1989-01       Impact factor: 4.897

6.  Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires : the Eating at America's Table Study.

Authors:  A F Subar; F E Thompson; V Kipnis; D Midthune; P Hurwitz; S McNutt; A McIntosh; S Rosenfeld
Journal:  Am J Epidemiol       Date:  2001-12-15       Impact factor: 4.897

7.  Distribution and Characteristics of Colonic Diverticula in a United States Screening Population.

Authors:  Anne F Peery; Tope O Keku; Christopher F Martin; Swathi Eluri; Thomas Runge; Joseph A Galanko; Robert S Sandler
Journal:  Clin Gastroenterol Hepatol       Date:  2016-02-09       Impact factor: 11.382

Review 8.  Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis.

Authors:  M Bashashati; N Rezaei; A Shafieyoun; D P McKernan; L Chang; L Öhman; E M Quigley; M Schmulson; K A Sharkey; M Simrén
Journal:  Neurogastroenterol Motil       Date:  2014-05-05       Impact factor: 3.598

9.  Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study.

Authors:  Hye-Kyung Jung; Rok Seon Choung; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; Nicholas J Talley
Journal:  Am J Gastroenterol       Date:  2009-10-27       Impact factor: 10.864

Review 10.  The Role of Mast Cells in Irritable Bowel Syndrome.

Authors:  Kang Nyeong Lee; Oh Young Lee
Journal:  Gastroenterol Res Pract       Date:  2016-12-28       Impact factor: 2.260

View more
  16 in total

1.  Ultrastructural changes of the human enteric nervous system and interstitial cells of Cajal in diverticular disease.

Authors:  Paulius Alaburda; Jaune I Lukosiene; Audrys G Pauza; Kristina Rysevaite-Kyguoliene; Juozas Kupcinskas; Zilvinas Saladzinskas; Algimantas Tamelis; Neringa Pauziene
Journal:  Histol Histopathol       Date:  2019-06-12       Impact factor: 2.303

Review 2.  Interactions of tea catechins with intestinal microbiota and their implication for human health.

Authors:  Tongtong Guo; Dan Song; Lu Cheng; Xin Zhang
Journal:  Food Sci Biotechnol       Date:  2019-08-08       Impact factor: 2.391

Review 3.  Pathophysiology of Diverticular Disease: From Diverticula Formation to Symptom Generation.

Authors:  Maria Raffaella Barbaro; Cesare Cremon; Daniele Fuschi; Giovanni Marasco; Marta Palombo; Vincenzo Stanghellini; Giovanni Barbara
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

4.  Does Subclinical Inflammation Play a Role in the Pathogenesis of Diverticulosis?

Authors:  Wenjie Ma; Andrew T Chan
Journal:  Clin Gastroenterol Hepatol       Date:  2017-11-15       Impact factor: 11.382

Review 5.  Colonic diverticular disease.

Authors:  Antonio Tursi; Carmelo Scarpignato; Lisa L Strate; Angel Lanas; Wolfgang Kruis; Adi Lahat; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-03-26       Impact factor: 52.329

Review 6.  Epidemiology, Pathophysiology, and Treatment of Diverticulitis.

Authors:  Lisa L Strate; Arden M Morris
Journal:  Gastroenterology       Date:  2019-01-17       Impact factor: 22.682

Review 7.  The Pathophysiology of Colonic Diverticulosis: Inflammation versus Constipation?

Authors:  Walter Elisei; Antonio Tursi
Journal:  Inflamm Intest Dis       Date:  2018-06-28

8.  An Aberrant Microbiota is not Strongly Associated with Incidental Colonic Diverticulosis.

Authors:  Roshonda B Jones; Anthony A Fodor; Anne F Peery; Matthew C B Tsilimigras; Kathryn Winglee; Amber McCoy; Michael Sioda; Robert S Sandler; Temitope O Keku
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

Review 9.  Recent advances in understanding and managing diverticulitis.

Authors:  Carola Severi; Marilia Carabotti; Alessia Cicenia; Lucia Pallotta; Bruno Annibale
Journal:  F1000Res       Date:  2018-06-29

10.  Development and validation of a diverticular clinical score for symptomatic uncomplicated diverticular disease after acute diverticulitis in a prospective patient cohort.

Authors:  Adi Lahat; Herma H Fidder; Shomron Ben-Horin
Journal:  Therap Adv Gastroenterol       Date:  2020-05-08       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.